Chongqing Taiji Industry Group Co Ltd banner
C

Chongqing Taiji Industry Group Co Ltd
SSE:600129

Watchlist Manager
Chongqing Taiji Industry Group Co Ltd
SSE:600129
Watchlist
Price: 15.56 CNY 0.32% Market Closed
Market Cap: ¥8.6B

P/E

71.2
Current
177%
More Expensive
vs 3-y average of 25.7

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
71.2
=
Market Cap
¥9B
/
Net Income
¥120.6m

Price to Earnings (P/E) ratio shows how much investors pay for each dollar of a company`s earnings. It`s calculated by dividing the company`s market value by its total earnings.

P/E
71.2
=
Market Cap
¥9B
/
Net Income
¥120.6m

Valuation Scenarios

Chongqing Taiji Industry Group Co Ltd is trading above its 3-year average

If P/E returns to its 3-Year Average (25.7), the stock would be worth ¥5.61 (64% downside from current price).

Statistics
Positive Scenarios
0/4
Maximum Downside
-64%
Maximum Upside
No Upside Scenarios
Average Downside
63%
Scenario P/E Value Implied Price Upside/Downside
Current Multiple 71.2 ¥15.56
0%
3-Year Average 25.7 ¥5.61
-64%
5-Year Average 25.7 ¥5.61
-64%
Industry Average 25.5 ¥5.58
-64%
Country Average 29.6 ¥6.48
-58%

Forward P/E
Today’s price vs future net income

Today's Market Cap Net Income Forward P/E
¥9B
/
Jan 2026
¥120.6m
=
71.2
Current
¥9B
/
Dec 2026
¥460.6m
=
19.5
Forward
¥9B
/
Dec 2027
¥593.4m
=
15.1
Forward
¥9B
/
Dec 2028
¥635.5m
=
14.1
Forward

Forward P/E shows whether today’s P/E still looks high or low once future net income are taken into account.

Market Distribution

Higher than 75% of companies in China
Percentile
75th
Based on 5 557 companies
75th percentile
71.2
Low
0 — 17.1
Typical Range
17.1 — 57.7
High
57.7 —
Distribution Statistics
China
Min 0
30th Percentile 17.1
Median 29.6
70th Percentile 57.7
Max 43 569.3

Chongqing Taiji Industry Group Co Ltd
Glance View

Market Cap
8.6B CNY
Industry
Pharmaceuticals

Amidst the sprawling urban landscape of Chongqing, a city often enveloped in a mystical cloak of fog, stands Chongqing Taiji Industry Group Co Ltd., a distinguished entity in the realm of pharmaceuticals. Commanding a legacy that spans over a century, Taiji Industry has mastered the delicate fusion of traditional Chinese medicine with modern pharmaceutical processes. This synthesis has propelled the company to the forefront of China's healthcare sector. The company’s operations revolve around robust research and development, manufacturing, and distribution, focusing on a diverse array of pharmaceutical products, health supplements, and TCM (Traditional Chinese Medicine) remedies. Seamlessly integrating innovation with traditional wisdom, the group has built an extensive portfolio catering to a wide range of medical needs, from cardiovascular treatments to neurological supports. Financially, Taiji Industry's prowess is underpinned by its diverse revenue streams, primarily flowing from its broad spectrum of medicinal drugs and health products. The company has capitalized on its established brand and extensive distribution networks, which span across the vast Chinese landscape and extend their reach into international markets. Their stronghold in distribution is further solidified by strategic collaborations with healthcare providers and retail pharmacy chains, ensuring reliable market penetration and accessibility to the end consumer. This well-oiled machine not only secures Taiji's position as a major pharmaceutical player but also drives its financial growth, allowing the company to invest continuously in innovation, quality enhancement, and market expansion. The synergistic blend of tradition and modernity continues to propel Taiji Industry through the ever-evolving pharmaceutical landscape.

Intrinsic Value
22.89 CNY
Undervaluation 32%
Intrinsic Value
Price ¥15.56
C
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett